Assessment of the efficacy of aerosolized antibody-based therapies for respiratory diseases in relevant preclinical models.

13 November 2020

We are pleased to announce that  Cynbiose and Cynbiose Respiratory will present their combined expertise at the 8th edition of the Antibody Industrial Symposium, November 23 – 26th, 2020.

Assessment of the efficacy of aerosolized antibody-based therapies for respiratory diseases in relevant preclinical models”. Dalloneau E, Confais J, Contamin H.

Share this!